CoChat

A computational neurodegenerative disease progression score: Method and results with the Alzheimer's disease neuroimaging initiative cohort

Open access
Jedynak, Bruno M., Lang, Andrew, Liu, Bo, Katz, Elyse, Zhang, Yanwei, Wyman, Bradley T., Raunig, David, Jedynak, C. Pierre, Caffo, Brian, Prince, Jerry L. · 2012 · NeuroImage
Cited by 243

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

While neurodegenerative diseases are characterized by steady degeneration over relatively long timelines, it is widely believed that the early stages are the most promising for therapeutic intervention, before irreversible neuronal loss occurs. Developing a therapeutic response requires a precise measure of disease progression. However, since the early stages are for the most part asymptomatic, obtaining accurate measures of disease progression is difficult. Longitudinal databases of hundreds of subjects observed during several years with tens of validated biomarkers are becoming available, allowing the use of computational methods. We propose a widely applicable statistical methodology for creating a disease progression score (DPS), using multiple biomarkers, for subjects with a neurodegenerative disease. The proposed methodology was evaluated for Alzheimer’s disease (AD) using the publicly available AD Neuroimaging Initiative (ADNI) database, yielding an Alzheimer’s DPS or ADPS score for each subject and each time-point in the database. In addition, a common description of biomarker changes was produced allowing for an ordering of the biomarkers. The Rey Auditory Verbal Learning Test delayed recall was found to be the earliest biomarker to become abnormal. The group of biomarkers comprising the volume of the hippocampus and the protein concentration amyloid beta and Tau were next in the timeline, and these were followed by three cognitive biomarkers. The proposed methodology thus has potential to stage individuals according to their state of disease progression relative to a population and to deduce common behaviors of biomarkers in the disease itself.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuroimage.2012.07.059

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 27

  1. Ashford, 1995, Temporal quantification of Alzheimer's disease severity: ‘Time Index’ model, Dementia, 6, 269
  2. Berg, 1988, Mild senile dementia of the alzheimer type: 2. Longitudinal assessment, Ann. Neurol., 23, 477, 10.1002/ana.410230509 · DOI · Paper page
  3. Brooks, 1993, The methodology of studying decline in Alzheimer's disease, J. Am. Geriatr. Soc., 41, 623, 10.1111/j.1532-5415.1993.tb06734.x · DOI · Paper page
  4. Carroll, 1997, Generalized partially linear single-index models, J. Am. Stat. Assoc., 92, 477, 10.1080/01621459.1997.10474001 · DOI · Paper page
  5. Duara, 2011, Pre-MCI and MCI: neuropsychological, clinical, and imaging features and progression rates, Am. J. Geriatr. Psychiatry, 19, 951, 10.1097/JGP.0b013e3182107c69 · DOI · Paper page
  6. Dubois, 2007, Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria, Lancet Neurol., 6, 734, 10.1016/S1474-4422(07)70178-3 · DOI · Paper page
  7. Folstein, 1975, “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician, J. Psychiatr. Res., 12, 189, 10.1016/0022-3956(75)90026-6 · DOI · Paper page
  8. Hampel, 2008, Core candidate neurochemical and imaging biomarkers of Alzheimer's disease, Alzheimers Dement., 4, 38, 10.1016/j.jalz.2007.08.006 · DOI · Paper page
  9. Hardle, 1993, Optimal smoothing in single-index models, Ann. Stat., 21, 157, 10.1214/aos/1176349020 · doi:10.1214/aos/1176349020
  10. Hinrichs, 2011, Predictive markers for AD in a multi-modality framework: an analysis of MCI progression in the ADNI population, NeuroImage, 55, 574, 10.1016/j.neuroimage.2010.10.081 · DOI · Paper page
  11. Jack, 2011, Evidence for ordering of alzheimer disease biomarkers, Arch. Neurol., 68, 1526, 10.1001/archneurol.2011.183 · DOI · Paper page
  12. Jicha, 2010, Conceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative disease, J. Alzheimers Dis., 19, 253, 10.3233/JAD-2010-1237 · DOI · Paper page
  13. Levenberg, 1944, A method for the solution of certain non-linear problems in least squares, Q. Appl. Math., 2, 164, 10.1090/qam/10666 · DOI · Paper page
  14. Martin, 2002, vol. 3, 441
  15. Mitnitski, 1999, Modeling decline in Alzheimer's disease, Int. Psychogeriatr., 11, 211, 10.1017/S1041610299005761 · doi:10.1017/s1041610299005761
  16. Mosconi, 2007, Early detection of Alzheimer's disease using neuroimaging, Exp. Gerontol., 42, 129, 10.1016/j.exger.2006.05.016 · DOI · Paper page
  17. Mungas, 2000, Application of item response theory for development of a global functioning measure of dementia with linear measurement properties, Stat. Med., 19, 1631, 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1631::AID-SIM451>3.0.CO;2-P · DOI · Paper page
  18. Qiu, 2008, Parallel transport in diffeomorphisms distinguishes time-dependent hippocampal surface atrophy in healthy aging and Alzheimer's disease, NeuroImage, 40, 68, 10.1016/j.neuroimage.2007.11.041 · DOI
  19. Richards, 1959, A flexible growth function for emperical use, J. Exp. Bot., 10, 290, 10.1093/jxb/10.2.290 · DOI · Paper page
  20. Sabuncu, 2011, The dynamics of cortical and hippocampal atrophy in Alzheimer disease, Arch. Neurol., 68, 1040, 10.1001/archneurol.2011.167 · DOI · Paper page
  21. Shaw, 2005, Molecular and cellular pathways of neurodegeneration in motor neurone disease, J. Neurol. Neurosurg. Psychiatry, 76, 1046, 10.1136/jnnp.2004.048652 · DOI · Paper page
  22. Stern, 1994, A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration, Am. J. Psychiatry, 151, 390, 10.1176/ajp.151.3.390 · DOI · Paper page
  23. Turner, 2009, Biomarkers in amyotrophic lateral sclerosis, Lancet Neurol., 8, 94, 10.1016/S1474-4422(08)70293-X · DOI · Paper page
  24. Turner, 2011, Towards a neuroimaging biomarker for amyotrophic lateral sclerosis, Lancet Neurol., 10, 400, 10.1016/S1474-4422(11)70049-7 · DOI · Paper page
  25. Walhovd, 2010, Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease, AJNR Am. J. Neuroradiol., 31, 347, 10.3174/ajnr.A1809 · DOI · Paper page
  26. Yang, 2011, Quantifying the pathophysiological timeline of Alzheimer's disease, J. Alzheimers Dis., 26, 745, 10.3233/JAD-2011-110551 · DOI · Paper page
  27. Yang, 2011, Independent component analysis-based classification of Alzheimer's disease mri data, J. Alzheimers Dis., 24, 775, 10.3233/JAD-2011-101371 · DOI · Paper page

Cited by

See all 243

Metadata

Authors
Jedynak, B. M., Lang, A., Liu, B., Katz, E., Zhang, Y., Wyman, B. T., Raunig, D., Jedynak, C. P., Caffo, B., & Prince, J. L.
Venue
NeuroImage
Publisher
Elsevier BV
Published
2012-11
Volume
63
Issue
3
Pages
1478-1486
ISSN
1053-8119 (ISSN-L)
OpenAlex
W2168818001
Cited by
243
References
6
FWCI
7.58
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • Pfizer Inc
  • National Institute of Biomedical Imaging and Bioengineering (P41EB015909, R01EB012547)
  • Ossoff Scholar Award
  • National Institutes of Health (U01 AG024904)
  • NIH (P30 AG010129, K01 AG030514)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.